|
1
|
Jones C, Pollit V, Fitzmaurice D and Cowan
C; Guideline Development Group: The management of atrial
fibrillation: Summary of updated NICE guidance. BMJ. 348:g36552014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Bruijn RF, Heeringa J, Wolters FJ,
Franco OH, Stricker BH, Hofman A, Koudstaal PJ and Ikram MA:
Association between atrial fibrillation and dementia in the general
population. JAMA Neurol. Sep 21–2015.Epub ahead of print.
View Article : Google Scholar
|
|
3
|
Schotten U, Hatem S, Ravens U, Jaïs P,
Müller FU, Goette A, Rohr S, Antoons G, Pieske B, Scherr D, et al
EUTRAF investigators: The European network for translational
research in atrial fibrillation (EUTRAF): Objectives and initial
results. Europace. Sep 12–2015.Epub ahead of print. View Article : Google Scholar
|
|
4
|
Patel NJ, Patel A, Agnihotri K, Pau D,
Patel S, Thakkar B, Nalluri N, Asti D, Kanotra R, Kadavath S, et
al: Prognostic impact of atrial fibrillation on clinical outcomes
of acute coronary syndromes, heart failure and chronic kidney
disease. World J Cardiol. 7:397–403. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Desai NR and Giugliano RP: Can we predict
outcomes in atrial fibrillation? Clin Cardiol. 35(Suppl 1): 10–14.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fedida D, Wible B, Wang Z, Fermini B,
Faust F, Nattel S and Brown AM: Identity of a novel delayed
rectifier current from human heart with a cloned K+ channel
current. Circ Res. 73:210–216. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li GR, Feng J, Yue L, Carrier M and Nattel
S: Evidence for two components of delayed rectifier K+ current in
human ventricular myocytes. Circ Res. 78:689–696. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Naz S, Siddiqi R, Ahmad S, Rasool SA and
Sayeed SA: Antibacterial activity directed isolation of compounds
from Punica granatum. J Food Sci. 72:M341–345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Phillips PA, Sangwan V, Borja-Cacho D,
Dudeja V, Vickers SM and Saluja AK: Myricetin induces pancreatic
cancer cell death via the induction of apoptosis and inhibition of
the phosphati-dylinositol 3-kinase (PI3K) signaling pathway. Cancer
Lett. 308:181–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siegelin MD, Gaiser T, Habel A and
Siegelin Y: Myricetin sensitizes malignant glioma cells to
TRAIL-mediated apoptosis by down-regulation of the short isoform of
FLIP and bcl-2. Cancer Lett. 283:230–238. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park HH, Lee S, Son HY, Park SB, Kim MS,
Choi EJ, Singh TS, Ha JH, Lee MG, Kim JE, et al: Flavonoids inhibit
histamine release and expression of proinflammatory cytokines in
mast cells. Arch Pharm Res. 31:1303–1311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Geraets L, Moonen HJ, Brauers K, Wouters
EF, Bast A and Hageman GJ: Dietary flavones and flavonoles are
inhibitors of poly (ADP-ribose) polymerase-1 in pulmonary
epithelial cells. J Nutr. 137:2190–2195. 2007.PubMed/NCBI
|
|
13
|
Medeiros KC, Figueiredo CA, Figueredo TB,
Freire KR, Santos FA, Alcantara-Neves NM, Silva TM and Piuvezam MR:
Anti-allergic effect of bee pollen phenolic extract and myricetin
in ovalbumin-sensitized mice. J Ethnopharmacol. 119:41–46. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang KA, Wang ZH, Zhang R, Piao MJ, Kim
KC, Kang SS, Kim YW, Lee J, Park D and Hyun JW: Myricetin protects
cells against oxidative stress-induced apoptosis via regulation of
PI3K/Akt and MAPK signaling pathways. Int J Mol Sci. 11:4348–4360.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sim GS, Lee BC, Cho HS, Lee JW, Kim JH,
Lee DH, Kim JH, Pyo HB, Moon DC, Oh KW, et al: Structure activity
relationship of antioxidative property of flavonoids and inhibitory
effect on matrix metalloproteinase activity in UVA-irradiated human
dermal fibroblast. Arch Pharm Res. 30:290–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghaffari MA and Mojab S: Influence of
flavonols as in vitro on low density lipoprotein glycation. Iran
Biomed J. 11:185–191. 2007.PubMed/NCBI
|
|
17
|
Matić S, Stanić S, Bogojević D, Vidaković
M, Grdović N, Dinić S, Solujić S, Mladenović M, Stanković N and
Mihailović M: Methanol extract from the stem of Cotinus coggygria
Scop., and its major bioactive phytochemical constituent myricetin
modulate pyrogallol-induced DNA damage and liver injury. Mutat Res.
755:81–89. 2013. View Article : Google Scholar
|
|
18
|
Ong KC and Khoo HE: Biological effects of
myricetin. Gen Pharmacol. 29:121–126. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scarabelli TM, Mariotto S, Abdel-Azeim S,
Shoji K, Darra E, Stephanou A, Chen-Scarabelli C, Marechal JD,
Knight R, Ciampa A, et al: Targeting STAT1 by myricetin and
delphinidin provides efficient protection of the heart from
ischemia/reperfusion-induced injury. FEBS Lett. 583:531–541. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tiwari R, Mohan M, Kasture S, Maxia A and
Ballero M: Cardioprotective potential of myricetin in
isoproterenol-induced myocardial infarction in Wistar rats.
Phytother Res. 23:1361–1366. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Borde P, Mohan M and Kasture S: Effect of
myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive
rats. Nat Prod Res. 25:1549–1559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Godse S, Mohan M, Kasture V and Kasture S:
Effect of myricetin on blood pressure and metabolic alterations in
fructose hypertensive rats. Pharm Biol. 48:494–498. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu JX: Effects of HMM on the hKv1.5
channel in HEK293 cells (unpublished PhD thesis). Huazhong
University of Science and Technology; 2010
|
|
24
|
Feng J, Wible B, Li GR, Wang Z and Nattel
S: Antisense oligodeoxynucleotides directed against Kv1.5 mRNA
specifically inhibit ultrarapid delayed rectifier K+ current in
cultured adult human atrial myocytes. Circ Res. 80:572–579. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ou XH, Li ML, Liu R, Fan XR, Mao L, Fan
XH, Yang Y and Zeng XR: Remodeling of Kv1.5 channel in right atria
from Han Chinese patients with atrial fibrillation. Med Sci Monit.
21:1207–1213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baczko I, Liknes D, Yang W, Hamming KC,
Searle G, Jaeger K, Husti Z, Juhasz V, Klausz G, Pap R, et al:
Characterization of a novel multifunctional resveratrol derivative
for the treatment of atrial fibrillation. Br J Pharmacol.
171:92–106. 2014. View Article : Google Scholar :
|
|
27
|
Lawrance CP, Henn MC and Damiano RJ Jr:
Surgery for atrial fibrillation. Cardiol Clin. 32:563–571. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prystowsky EN, Padanilam BJ and Fogel RI:
Treatment of atrial fibrillation. JAMA. 314:278–288. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abo-Salem E, Lockwood D, Boersma L, Deneke
T, Pison L, Paone RF and Nugent KM: Surgical Treatment of Atrial
Fibrillation. J Cardiovasc Electrophysiol. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Reiffel JA, Camm AJ, Belardinelli L, Zeng
D, Karwatowska-Prokopczuk E, Olmsted A, Zareba W, Rosero S and
Kowey P; HARMONY Investigators: The HARMONY trial: Combined
ranolazine and dronedarone in the management of paroxysmal atrial
fibrillation: Mechanistic and therapeutic synergism. Circ Arrhythm
Electrophysiol. 8:1048–1056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Christ T and Ravens U: Do we need new
antiarrhythmic compounds in the era of implantable cardiac devices
and percutaneous ablation? Cardiovasc Res. 68:341–343. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu J, Jia YY, Chen SR, Ye JT, Bu XZ, Hu Y,
Ma YZ, Guo JL and Liu PQ:
(E)-1-(4-ethoxyphenyl)-3-(4-nitrophenyl)-prop-2-en-1-one suppresses
LPS-induced inflammatory response through inhibition of NF-κB
signaling pathway. Int Immunopharmacol. 15:743–751. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Glossman-Mitnik D: A comparison of the
chemical reactivity of naringenin calculated with the M06 family of
density functionals. Chem Cent J. 7:1552013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kumar S and Pandey AK: Chemistry and
biological activities of flavonoids: An overview. Scientific World
Journal. 2013:1627502013. View Article : Google Scholar
|
|
35
|
Dayoub O, Andriantsitohaina R and Clere N:
Pleiotropic beneficial effects of epigallocatechin gallate,
quercetin and delphinidin on cardiovascular diseases associated
with endothelial dysfunction. Cardiovasc Hematol Agents Med Chem.
11:249–264. 2013. View Article : Google Scholar
|
|
36
|
Singh M, Kaur M and Silakari O: Flavones:
An important scaffold for medicinal chemistry. Eur J Med Chem.
84:206–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Islam MA: Cardiovascular effects of green
tea catechins: Progress and promise. Recent Pat Cardiovasc Drug
Discov. 7:88–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li J, Zhang J, Dong X, Deng H and Yang F:
Quercetin protects against lipopolysaccharide-induced cardiac
injury in mice. Nan Fang Yi Ke Da Xue Xue Bao. 35:1068–1072.
2015.In Chinese. PubMed/NCBI
|
|
39
|
Roohbakhsh A, Parhiz H, Soltani F, Rezaee
R and Iranshahi M: Molecular mechanisms behind the biological
effects of hesperidin and hesperetin for the prevention of cancer
and cardiovascular diseases. Life Sci. 124:64–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zholobenko A and Modriansky M: Silymarin
and its constituents in cardiac preconditioning. Fitoterapia.
97:122–132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liew R, Stagg MA, Chan J, Collins P and
MacLeod KT: Gender determines the acute actions of genistein on
intracellular calcium regulation in the guinea-pig heart.
Cardiovasc Res. 61:66–76. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li GR, Wang HB, Qin GW, Jin MW, Tang Q,
Sun HY, Du XL, Deng XL, Zhang XH, Chen JB, et al: Acacetin, a
natural flavone, selectively inhibits human atrial repolarization
potassium currents and prevents atrial fibrillation in dogs.
Circulation. 117:2449–2457. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Y, Fu L, Wang L, Xu L and Yang B:
Electrophysiological study on the antiarrhythmic mechanism of
ampelopsin in rats. Zhonghua Xin Xue Guan Bing Za Zhi. 42:675–679.
2014.In Chinese. PubMed/NCBI
|
|
44
|
Huang H, Chen AY, Ye X, Li B, Rojanasakul
Y, Rankin GO and Chen YC: Myricetin inhibits proliferation of
cisplatin-resistant cancer cells through a p53-dependent apoptotic
pathway. Int J Oncol. 47:1494–1502. 2015.PubMed/NCBI
|
